GlobeNewswire PharmaOriginal article
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
EarningsNegative
AI Analysis
Summary
Natural Alternatives International reported a net loss of $13.5 million ($2.23 per diluted share) on net sales of $34.5 million for Q4 FY2026, including a $10.4 million non-cash impairment charge related to underutilization of its Carlsbad manufacturing facility.
Financial Highlights
Revenue
$34.5 million
EPS
($2.23) per diluted share
Importance:3/10
Sentiment:
-0.70
earningsnet lossQ4 FY2026impairment chargemanufacturing facility
Related Companies
Read the original article
Published by GlobeNewswire Pharma on September 28, 2026 8:30 PM
